新生儿基因组测序发现,比标准血液测试更可预防或可治疗的健康状况。 Genome sequencing of newborns identifies more preventable or treatable health conditions than standard blood tests.

New York-Presbyterian/Columbia大学的一项研究发现,新生儿基因组测序比常规血液检测可发现更多可预防或可治疗的健康状况。 A study from NewYork-Presbyterian/Columbia University found that genome sequencing of newborns can identify many more preventable or treatable health conditions than conventional blood tests. 研究人员对4 000名新生儿进行了分析,发现120人病情严重,而标准方法只有10人病情严重。 Analyzing 4,000 newborns, researchers detected 120 serious conditions, compared to just 10 through standard methods. 他们主张将基因组测序作为一项新标准,因为它可能发现数千种遗传疾病,为婴儿提供更广泛的健康保护。 They advocate for genome sequencing as a new standard, as it could uncover thousands of genetic diseases, offering broader health protections for infants.